Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD -3.45%12 Return-on-Tangible-Equity is 13.02% as of Mar. 2026, which is 43% below its 10-year median of 22.84. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 12/100. The stock has 7 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Vijaypd Ceutical ranks better than 78.3% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Vijaypd Ceutical's annualized net income for the quarter that ended in Mar. 2026 was ₹50 Mil. Vijaypd Ceutical's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹384 Mil. Therefore, Vijaypd Ceutical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 13.02%.
The historical rank and industry rank for Vijaypd Ceutical's Return-on-Tangible-Equity or its related term are showing as below:
NSE:VIJAYPD'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.68 Med: 22.84 Max: 55.68
Current: 13.02
During the past 4 years, Vijaypd Ceutical's highest Return-on-Tangible-Equity was 55.68%. The lowest was 3.68%. And the median was 22.84%.
NSE:VIJAYPD's Return-on-Tangible-Equity is ranked better than 78.3% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs NSE:VIJAYPD: 13.02
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Vijaypd Ceutical Return-on-Tangible-Equity Related Terms
Vijaypd Ceutical Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.02% mean?
Vijaypd Ceutical (NSE:VIJAYPD) has a Return-on-Tangible-Equity of 13.02% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vijaypd Ceutical and its competitors. This is 43% below median its historical median of 22.84. Over the past decade, Vijaypd Ceutical's Return-on-Tangible-Equity has ranged from 3.68 to 55.68. According to the industry distribution chart, Vijaypd Ceutical ranks #125 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 21.7%.
Is Vijaypd Ceutical's Return-on-Tangible-Equity too high?
Vijaypd Ceutical's current Return-on-Tangible-Equity of 13.02% is 43% below median its 10-year median of 22.84. Over the past 10 years, this metric has ranged from a low of 3.68 to a high of 55.68. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Vijaypd Ceutical's value of 13.02% is 28% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #125 out of 576 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaypd Ceutical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #125 out of 576 companies for Return-on-Tangible-Equity. This places Vijaypd Ceutical in the top 22% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.17. Vijaypd Ceutical's value of 13.02% is 28% above this benchmark. Historically, Vijaypd Ceutical's own Return-on-Tangible-Equity has ranged from 3.68 to 55.68 over the past decade. While the company's 10-year median is 22.84 vs. the industry median of 10.17, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current Return-on-Tangible-Equity of 13.02% is 28% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current Return-on-Tangible-Equity is 13.02%, which is 43% below median its own 10-year median of 22.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current Return-on-Tangible-Equity of 13.02%. The current Return-on-Tangible-Equity is 13.02%, which is 43% below median its 10-year median of 22.84 and 28% above the Healthcare Providers & Services industry median of 10.17. Vijaypd Ceutical's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current Return-on-Tangible-Equity is 13.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
12GF Score
Get the complete analysis for NSE:VIJAYPD
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
